Epidemiology of cardiovascular disease in chronic renal disease
By Robert N. Foley. 2000
1,296 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine
View Paper: https://www.semanticscholar.org/paper/9a05df801d467d1fb7a82f28c504de76c7e3cb11
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
Citations in the corpus
- Survival advantages of obesity in dialysis patients. (2005, background): “Extrapolation of findings from the general population has led to decades of focusing on treating such conventional CVD risk factors in dialysis patients as obesity, hypertension, hypercholesterolemia, and hyperhomocysteinemia.”
- Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Coun (2008, background): “OSA could further contribute to the progression of ESRD by acutely increasing sympathetic nerve discharge directed at the kidney and other vascular beds, raising BP during episodes of upper airway occlusion, and chronically accelerating the progression of renal damage (293,294), with sustained eleva”
- Hemodialysis-induced cardiac injury: determinants and associated outcomes. (2009, background): “D ialysis patients display hugely elevated rates of cardiac mortality (1), and this rate of cardiovascular attrition is not driven by the same risk factors, or pathophysiological processes, that are important in the general population (2).”
- Cardiovascular and noncardiovascular mortality among patients starting dialysis. (2009, background): “This is in accordance with other studies demonstrating a 10- to 20-fold increased cardiovascular mortality risk for patients receiving dialysis.(4,6) The present analysis added that noncardiovascular mortality was 14-fold higher in such patients than in the general population.”